Simon Lehle
About Simon Lehle
Simon Lehle is a Senior Product Manager Sub-Region Europe at BeiGene in Basel, Switzerland, with extensive experience in product management and a strong background in biochemistry and molecular medicine.
Current Position at BeiGene
Simon Lehle currently holds the position of Senior Product Manager Sub-Region Europe at BeiGene. Based in Basel, Schweiz, he brings extensive experience in product management within the pharmaceutical industry to his role. His responsibilities likely involve overseeing product strategies and operations across Europe, contributing to BeiGene's growth and market presence in the region.
Previous Roles at Roche
Before joining BeiGene, Simon Lehle worked at Roche for several years in multiple capacities. He served as a Product Manager Hematology from 2019 to 2021, focusing on hematological products. He also held the role of Commercial Excellence Manager from 2018 to 2021, where he worked on improving commercial strategies and operations. Earlier in his tenure at Roche, he was a Management Startup Trainee in Marketing from 2015 to 2018 in Grenzach-Wyhlen.
Tenure at MorphoSys
Simon Lehle was employed at MorphoSys as a Senior Global Product Manager from 2021 to 2022 for nine months. During his time there, based in the Metropolregion München, he would have taken on senior responsibilities in managing global pharmaceutical products, contributing to the company's strategic objectives in the industry.
Educational Background
Simon Lehle's strong academic foundation includes a PhD in Molecular Medicine from Eberhard Karls Universität Tübingen, obtained between 2010 and 2013. He also studied Biochemistry at Ludwig-Maximilians Universität München in 2008 and at Harvard University from 2007 to 2008. He earned a Diplom in Biochemistry from Eberhard-Karls-Universität Tübingen, completing his studies there from 2004 to 2010.
Early Career and Research Experience
Simon Lehle started his career with a trainee position in protein biochemistry at SuppreMol GmbH in 2008. He also worked as a Scientist there from 2009 to 2010. He then moved to Universitätsklinikum Tübingen, where he served as a Doctoral Student, postdoctoral Scientist, and Group Leader between 2010 and 2014. His research during this period focused on molecular medicine, DNA damage, and apoptosis in stem cells. He briefly worked as a Scientist at QIAGEN in 2014.